QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

ASMB

QT41Assembly Biosciences, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
24.44
+0.29+1.20%
OverviewShort InterestFilings
ASMBQT41Assembly Biosciences, Inc.·NASDAQ
OverviewShort InterestFilings
24.44+1.20%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-0.58
Insider Own-
Shs Outstand19.82M
Perf Week8.48%
Market Cap383.81MForward P/E-EPS next Y-3.21Insider Trans-0.00%Shs Float-Perf Month-7.84%
Enterprise Value355.18MPEG-EPS next Q-0.70Inst Own-Short Float-Perf Quarter-11.16%
Income-5987492.00P/S5.40EPS this Y-193.53%Inst Trans-Short Ratio-Perf Half Y-27.04%
Sales71.10MP/B2.06EPS next Y-88.55%ROA-2.71%Short Interest-Perf YTD-28.14%
Book/sh10.04P/C-EPS next 5Y-ROE-4.21%52W High39.71 -38.45%Perf Year43.09%
Cash/sh11.45P/FCF-EPS past 3/5Y-ROIC-6.74%52W Low16.50 48.12%Perf 3Y-
Dividend Est.-EV/EBITDA-56.73Sales past 3/5Y- -1.84%Gross Margin77.24%Volatility4.05% 4.77%Perf 5Y-
Dividend TTM-EV/Sales5.00EPS Y/Y TTM98.36%Oper. Margin-19.05%ATR (14)1.52Perf 10Y-
Dividend Ex-Date-Quick Ratio6.65Sales Y/Y TTM144.83%Profit Margin-8.98%RSI (14)44.81Recom2.45
Dividend Gr. 3/5Y-Current Ratio6.65EPS Q/Q53.85%SMA20-1.78%Beta1.38Target Price45.00
Payout0.00%Debt/Eq0.01Sales Q/Q-11.11%SMA50-10.10%Rel Volume1.80Prev Close24.15
Employees73LT Debt/Eq0.01EarningsAug 05SMA200-15.38%Avg Volume166.10KPrice24.44
IPO DateDec 17, 2010Option/ShortYes / YesEPS/Sales Surpr.26.03% -11.11%Net Debt/EBITDA4.57Volume298,858Change1.20%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-15-26ReiteratedMizuho Securities$40 → $45
Nov-20-25ReiteratedMizuho Securities$29 → $40
Sep-24-25InitiatedCitizens JMPOutperform$38
Sep-24-24ReiteratedMizuho Securities$36
Sep-20-24ReiteratedJefferiesHold$35
Oct-23-22DowngradeTruist SecuritiesBuy → Hold
Sep-01-21DowngradeWilliam BlairOutperform → Market Perform
Mar-22-21DowngradeSVB LeerinkOutperform → Market Perform
Nov-05-20DowngradeJefferiesBuy → Hold
Oct-08-18UpgradeB. Riley FBRNeutral → Buy
Latest News
Jun-15-26
Jun-15-2601:17PM
Mizuho Maintains Outperform on Assembly Biosciences, Raises Price Target to $45Benzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue717229
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A16056
Gross Profit5572-27
Selling, General and Administrative Excl. Other202018
Research and Development656556
Other Operating Expense-15-1-56
Operating Income-13-12-45
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)-7-6-6
Net Income Before Taxes-6-6-40
Income Taxes000
Consolidated Net Income-6-6-40
Net Income From Continuing Operations-6-6-40
Net Income-6-6-40
EPS (Recurring)-0.58-0.55-6.69
EPS (Basic, Before Extraordinaries)-0.58-0.55-6.69
EPS (Diluted)-0.58-0.55-6.69
EBITDA-6-6-40
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio5.855.20—
Gross Margin77.46100.00-93.10
Operating Margin-18.31-16.67-155.17
Net Margin-8.45-8.33-137.93
Shares Outstanding17116
Market Capitalization415374—
Operating Lease Expense
———
Insider Trading Volume
$25.39$23.50$21.61$19.72$17.83● Close Price0.00M12.40M24.80M37.20M49.59MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
White Nicole SChief Manufacturing OfficerMar 30 '26Sale26.691975,25737,477Mar 31 12:00 AM
Bjorkquist Jeanette MPFO and PAOMar 30 '26Sale26.693288,75511,089Mar 31 12:00 AM
GILEAD SCIENCES, INC.10% OwnerAug 08 '25Buy10.804,591,84049,594,1684,505,391Oct 03 12:00 AM
McHutchison John GDirectorMar 31 '25Sale9.857577,45518,347Apr 15 12:00 AM
Okazaki Jason ACEO and PresidentMar 31 '25Sale9.853553,49614,757Apr 01 12:00 AM
Bjorkquist Jeanette MPrincipal Accounting OfficerMar 31 '25Sale9.851801,7734,617Apr 01 12:00 AM
White Nicole SChief Manufacturing OfficerMar 31 '25Sale9.851971,94011,674Apr 01 12:00 AM
Houghton MichaelDirectorDec 30 '24Buy15.613,20249,9983,202Dec 31 12:00 AM
GILEAD SCIENCES, INC.10% OwnerDec 19 '24Buy21.37940,49920,098,4642,209,471Dec 23 12:00 AM
Schornstein Alexander10% OwnerNov 25 '24Buy14.917,976118,890728,113Nov 26 12:00 AM
Schornstein Alexander10% OwnerNov 22 '24Buy14.8717,024253,104720,137Nov 26 12:00 AM
White Nicole SChief Manufacturing OfficerNov 18 '24Sale16.294065211,871Nov 19 12:00 AM
Schornstein Alexander10% OwnerOct 08 '24Buy14.5810,000145,800703,113Oct 09 12:00 AM
Okazaki Jason ACEO and PresidentOct 03 '24Sale14.811972,91814,904Oct 04 12:00 AM
White Nicole SChief Manufacturing OfficerOct 03 '24Sale14.811572,32511,911Oct 04 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR